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Commentary: Should the analysis of observational data always be 
preceded by specifying a target experimental trial? 
 
Vanessa Didelez 
School of Mathematics, University of Bristol, Bristol, UK 
 
The recent paper by Cain et al. [1] deals with the important practical question of 
when to switch antiretroviral therapy for HIV-infected individuals after virologic 
failure. However, the real significance of the paper is in advocating, and 
demonstrating the feasibility of, what we may want to adopt as a general principle: 
analysing observational data by first specifying, as precisely as possible, and then 
emulating the ideal experimental trial for the question at hand so as to guide the 
analysis of the observational data. This is not the first instance of such an analysis 
[2], but they are still very (and too) rare. As demonstrated comprehensively by the 
authors [1], clarifying the ideal experimental trial steers the practical decisions that 
need to be made for the statistical analysis and its interpretation. 
 
Why is it important to specify and emulate the ideal experimental trial for the 
question at hand even if we ‘only’ have observational data? 
 
Facilitating Communication:  
It simplifies communication. While methods that deal with observed (and sometimes 
unobserved) confounders, such as propensity scores / inverse probability weighting, 
g-computation, instrumental variables, Mont-Carlo simulation providing marginal 
standardised effects etc., may in themselves be quite complicated and daunting, the 
target of inference and hence the interpretation of the outcome is made much clearer 
and simpler when formulated in terms of an ideal randomized trial. For instance in [1] 
we see that the results can be presented in a few plots with two survival curves 
each, even though a complex statistical analysis combing ‘cloning’, artificial (as well 
as other types of) censoring, inverse probability weighting, time-exposure 
interactions, standardization etc. has been used. In fact, causal frameworks, such as 
counterfactuals, structural equations, or do-calculus, can be regarded as languages 
for formulating an ideal interventional trial – however, they sometimes develop a life 
of their own that leads away from practically relevant questions. 
 
Asking meaningful questions: 
It forces us to ask meaningful questions and choose meaningful targets of inference 
that lead to practically useful results. A large aspect of this is that it forces us to 
consider feasible interventions. Many observational studies, for instance, consider 
the “causal effect” of BMI on health outcomes – how would this be reformulated in 
terms of an ideal experimental trial? We cannot ‘assign’ participants to different BMI 
values, so what is the meaning of such an analysis? Instead we may want to look at 
the effect of specific exercise regimes versus dietary changes versus gastric 
stapling. Similarly, many studies consider the “causal effect” of birth weight on long-
term outcomes; however, we cannot change the birth weight of a new-born at will; 
different realistic interventions that may change birth weight may do so in extremely 
different ways with very different effects. It may therefore be more relevant for 
practice to look at what behaviours and exposures affect birthweight as well as 
subsequent outcomes.  
 
Understanding assumptions: 
It helps with assessing and justifying or refuting the assumptions required to obtain 
causal conclusions from on observational data, such as ‘no unmeasured 
confounding’. It allows a concrete comparison between (i) what randomization, data 
and decisions we would have in the experimental setting, with (ii) the (possible lack 
of) randomization, data and decisions we actually have in the observational setting. 
In [1] the concrete example of the importance, but lack of, data on adherence and 
resistance illustrates this point. 
 
Avoid pitfalls with time dependent data: 
It is even more important to take this approach when faced with time-dependent data 
and especially time-dependent exposures or treatments. As becomes clear in the 
example of [1] even if we were to randomize subjects to one or the other switching 
strategies, there can be periods of time during follow-up where a given subject’s 
history conforms with both strategies. In an actual randomized trial, randomization 
will ensure that these types of subjects are at the outset comparable in both groups; 
in an observational trial the authors of [1] suggest to count them into both groups by 
'cloning' them (alternatively one could randomly assign them to just one group, but 
that would lead to an inefficient use of the already limited data). Mistakes like 
assigning to a control group all subjects who dropped out or died before actually 
being exposed or treated will then automatically be avoided. 
 
Guiding statistical analysis: 
It also forces us to use a statistical analysis that produces quantities that are 
analogous to those obtained from an experimental trial. In a randomized controlled 
trial with two groups it would be obvious to just plot the two survival curves where 
covariates would not normally be included. Hence, when analysing observational 
data we should target the same marginal effects, and not condition on covariates just 
because we need to adjust for them as potential confounders - this naturally leads to 
the use of Marginal Structural Models [3] (note that the authors of [1] plot the survival 
curves standardized by baseline covariates). An alternative would be to weight the 
Kaplan-Meier curves themselves [4] though in the context of dynamic treatment 
strategies this approach still needs further exploring. 
 
Some may argue that demanding, as a rule, that any analysis of observational data 
must be preceded by the specification of and emulate an experimental trial could be 
very limiting; for instance, one may want to look at 'effects' of BMI or birthweight on 
various outcomes in order to ‘generate hypotheses’ – my suggestion is that if this is 
the case then it should be clearly stated and the discussion should explicitly address 
how to translate the results into more practical questions for future research. On the 
other hand, we may find that specifying a target experimental trial could be very 
fruitful and enrich analyses of observational data as it may lead e.g. to new 
approaches to defining sensible exposures or treatments or better presentations of 
results. Clearly, observational and other non-experimental studies have many 
advantages over controlled randomized trials [5], but as an experiment, let’s try to 
complement their analysis by specifying an ideal target experimental trial for the 
research question at hand and see to what new ideas and findings this leads! 
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